BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18295252)

  • 1. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
    Thongboonkerd V; Chutipongtanate S; Semangoen T; Malasit P
    J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
    Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
    J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell membrane fragments but not intact red blood cells promote calcium oxalate monohydrate crystal growth and aggregation.
    Chutipongtanate S; Thongboonkerd V
    J Urol; 2010 Aug; 184(2):743-9. PubMed ID: 20639050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular cell membranes inhibit growth but promote aggregation of calcium oxalate monohydrate crystals.
    Chutipongtanate S; Thongboonkerd V
    Chem Biol Interact; 2010 Dec; 188(3):421-6. PubMed ID: 20797392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B; Nakagawa Y; Coe FL
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR; Arsenault D; Parks JH; Coe FL; Hoyer JR
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
    J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
    Noonin C; Peerapen P; Yoodee S; Kapincharanon C; Kanlaya R; Thongboonkerd V
    Chem Biol Interact; 2022 Apr; 357():109879. PubMed ID: 35263610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro.
    Atmani F; Khan SR
    BJU Int; 2000 Apr; 85(6):621-5. PubMed ID: 10759652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.